Recombinant SARS-CoV-2 Vaccine（variant）（Shanghai Zerun）
新型冠状病毒疫苗（变异株）（上海泽润）
Report date: 2022/11/17 20:00:51
Base Information
Drug NameRecombinant SARS-CoV-2 Vaccine（variant）（Shanghai Zerun）
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesShanghai Zerun Biotechnology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesShanghai Zerun Biotechnology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A